Výsledky vyhledávání - "Klaus D. Jakobsen"

Copy Number Variants and Polygenic Risk Scores Predict Need of Care in Autism and/or ADHD Families

Autor: Jette LaBianca, Alfonso Buil, Anne Katrine Pagsberg, Vivek Appadurai, Klaus D. Jakobsen, Thomas Werge, Sonja LaBianca

Publikováno v: Journal of Autism and Developmental Disorders. 51:276-285

Autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) are highly heritable neurodevelopmental disorders that frequently co-occur. Both rare and common genetic variants are important for ASD and ADHD risk but their combine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dfa81671cb37a50aeebcdd52831e204
https://doi.org/10.1007/s10803-020-04552-x

Zobrazit plný text záznamu

Pregabalin for anxiety in patients with schizophrenia — A randomized, double-blind placebo-controlled study

Autor: Klaus D. Jakobsen, Jimmi Nielsen, Ole Schjerning, Signe Engelhardt Lykkegaard, Per Damkier

Publikováno v: Schjerning, O, Damkier, P, Lykkegaard, S E, Jakobsen, K D & Nielsen, J 2018, ' Pregabalin for anxiety in patients with schizophrenia-A randomized, double-blind placebo-controlled study ', Schizophrenia Research, vol. 195, pp. 260-266 . https://doi.org/10.1016/j.schres.2017.09.014
Schjerning, O, Damkier, P, Lykkegaard, S E, Jakobsen, K D & Nielsen, J 2018, ' Pregabalin for anxiety in patients with schizophrenia : A randomized, double-blind placebo-controlled study ', Schizophrenia Research, vol. 195, pp. 260-266 . https://doi.org/10.1016/j.schres.2017.09.014

Introduction Anxiety is frequent in patients with schizophrenia and poses a major impact on patients perceived quality of life, daily functioning and risk of suicide. Pregabalin has shown effective in the treatment of generalized anxiety disorder and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3aafb3415122ccd4c8126482e62f573
https://doi.org/10.1016/j.schres.2017.09.014

Zobrazit plný text záznamu

Akademický článek

Brain expressed microRNAs implicated in schizophrenia etiology.

Autor: Thomas Hansen, Line Olsen, Morten Lindow, Klaus D Jakobsen, Henrik Ullum, Erik Jonsson, Ole A Andreassen, Srdjan Djurovic, Ingrid Melle, Ingrid Agartz, Håkan Hall, Sally Timm, August G Wang, Thomas Werge

Publikováno v: PLoS ONE, Vol 2, Iss 9, p e873 (2007)

BACKGROUND: Protein encoding genes have long been the major targets for research in schizophrenia genetics. However, with the identification of regulatory microRNAs (miRNAs) as important in brain development and function, miRNAs genes have emerged as

Externí odkaz: https://doaj.org/article/47cf13a7c2ac4e05983bee8e340ac739

Zobrazit plný text záznamu

Brief Report:Clusters and Trajectories Across the Autism and/or ADHD Spectrum

Autor: Sonja LaBianca, Klaus D. Jakobsen, J. LaBianca, A. B. Demur, Anne Katrine Pagsberg, M. Bartalan, Thomas Werge

Publikováno v: LaBianca, S, Pagsberg, A K, Jakobsen, K D, Demur, A B, Bartalan, M, LaBianca, J & Werge, T 2018, ' Brief Report : Clusters and Trajectories Across the Autism and/or ADHD Spectrum ', Journal of Autism and Developmental Disorders, vol. 48, no. 10, pp. 3629-3636 . https://doi.org/10.1007/s10803-018-3618-6

Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD) frequently co-occur and show high genetic correlation. With the introduction of DSM-5, there is a new concept of an ASD and/or ADHD spectrum (ASD/ADHD). This study aim

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fc8cc55d8cdec3c6378b415c89725c9
https://vbn.aau.dk/da/publications/4c674f7f-e2d1-4447-a9ca-d5244f27034d

Zobrazit plný text záznamu

Antipsychotic treatment of schizotypy and schizotypal personality disorder: a systematic review

Autor: Ole Schjerning, Eva Marie Skyum, Anders Fink-Jensen, Nasseh Hashemi, Klaus D. Jakobsen, Jimmi Nielsen

Publikováno v: Jakobsen, K D, Skyum, E M, Hashemi, N, Schjerning, O, Fink-Jensen, A & Nielsen, J 2017, ' Antipsychotic treatment of schizotypy and schizotypal personality disorder : a systematic review ', Journal of Psychopharmacology, vol. 31, no. 4, pp. 397-405 . https://doi.org/10.1177/0269881117695879

Schizotypal personality disorder (SPD) is characterised by thought disorders, experiences of illusions, obsessive ruminations, bizarre or eccentric behaviour, cognitive problems and deficits in social functioning – symptoms that SPD shares with sch

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4380e4571097c75cde3e75ce157c147e
https://pubmed.ncbi.nlm.nih.gov/28347257

Zobrazit plný text záznamu

Adverse events in children and adolescents treated with quetiapine:an analysis of adverse drug reaction reports from the Danish Medicines Agency database

Autor: Helle Wallach-Kildemoes, Anders Fink-Jensen, Christina Hedegård Bruhn, Klaus D. Jakobsen, Jimmi Nielsen, Nasseh Hashemi, Anne Katrine Pagsberg

Publikováno v: Jakobsen, K D, Wallach-Kildemoes, H, Bruhn, C H, Hashemi, N, Pagsberg, A K, Fink-Jensen, A & Nielsen, J 2017, ' Adverse events in children and adolescents treated with quetiapine : an analysis of adverse drug reaction reports from the Danish Medicines Agency database ', International Clinical Psychopharmacology, vol. 32, no. 2, pp. 103-106 . https://doi.org/10.1097/YIC.0000000000000148

Quetiapine is a low-affinity dopamine D2 receptor antagonist, approved for the treatment of bipolar disorder and schizophrenia in children and adolescents by the Food and Drug Administration, but not by European Medicine Agency. Although knowledge of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcc8bf2caa8c03439ed2ead6cf9f209f
https://vbn.aau.dk/da/publications/289e012e-d61a-433c-8cfc-37627656b0ab

Zobrazit plný text záznamu

Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole

Autor: Jimmi Nielsen, Anders Fink-Jensen, Klaus D. Jakobsen, Christina Hedegaard Bruhn, Anne-Katrine Pagsberg

Publikováno v: Jakobsen, K D, Bruhn, C H, Pagsberg, A-K, Fink-Jensen, A & Nielsen, J 2016, ' Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole ', Journal of Clinical Psychopharmacology, vol. 36, no. 5, pp. 496-499 . https://doi.org/10.1097/JCP.0000000000000548

Aripiprazole is a partial dopamine agonist with only minor neurological and psychiatric adverse effects, making it a potential first-line drug for the treatment of psychiatric disorders. However, the evidence of its use in children and adolescents is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93f1c14864e75cd0ca95dbbe2a59bc9d
https://vbn.aau.dk/da/publications/8a478585-7814-46e7-9be5-4192f35c32d9

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání